PT3442547T - Lactobacillus reuteri mm4-1a para utilização no tratamento ou prevenção de transtornos de espetro de autismo - Google Patents
Lactobacillus reuteri mm4-1a para utilização no tratamento ou prevenção de transtornos de espetro de autismoInfo
- Publication number
- PT3442547T PT3442547T PT177833431T PT17783343T PT3442547T PT 3442547 T PT3442547 T PT 3442547T PT 177833431 T PT177833431 T PT 177833431T PT 17783343 T PT17783343 T PT 17783343T PT 3442547 T PT3442547 T PT 3442547T
- Authority
- PT
- Portugal
- Prior art keywords
- disorders
- developmental
- probiotic therapies
- neurological
- neurological disorders
- Prior art date
Links
- 208000012239 Developmental disease Diseases 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662322946P | 2016-04-15 | 2016-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3442547T true PT3442547T (pt) | 2023-09-04 |
Family
ID=60042831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT177833431T PT3442547T (pt) | 2016-04-15 | 2017-04-15 | Lactobacillus reuteri mm4-1a para utilização no tratamento ou prevenção de transtornos de espetro de autismo |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11135252B2 (pt) |
| EP (2) | EP4238573A1 (pt) |
| DK (1) | DK3442547T3 (pt) |
| ES (1) | ES2954147T3 (pt) |
| FI (1) | FI3442547T3 (pt) |
| HR (1) | HRP20231030T1 (pt) |
| HU (1) | HUE062788T2 (pt) |
| LT (1) | LT3442547T (pt) |
| PL (1) | PL3442547T3 (pt) |
| PT (1) | PT3442547T (pt) |
| RS (1) | RS64503B1 (pt) |
| SI (1) | SI3442547T1 (pt) |
| WO (1) | WO2017181158A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE062788T2 (hu) * | 2016-04-15 | 2023-12-28 | Baylor College Medicine | Lactobacillus reuteri MM4-1A alkalmazása az autizmus spektrumzavar kezelésében vagy megelõzésében |
| KR102463809B1 (ko) * | 2019-05-24 | 2022-11-04 | 한국식품연구원 | 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 파라카세이 WiKim0110 균주 및 이를 포함하는 조성물 |
| US20230077300A1 (en) * | 2020-01-13 | 2023-03-09 | Scioto Biosciences, Inc. | Methods for treating or ameliorating autism and related disorders |
| WO2022147251A1 (en) * | 2020-12-30 | 2022-07-07 | The General Hospital Corporation | Methods and composition for the treatment of autism spectrum disorder |
| CN113180109B (zh) * | 2021-04-16 | 2022-02-18 | 段云峰 | 罗伊氏乳杆菌在制备预防或治疗发育障碍类疾病产品中的应用 |
| US12005044B1 (en) | 2022-11-29 | 2024-06-11 | Autism Therapeutics Inc. | Treatment of autism spectrum disorders with ergothioneine, selenoneine, or combinations thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413960A (en) | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
| DE60333857D1 (de) | 2002-10-03 | 2010-09-30 | Neuropharmacology Services Llc | Oxytocin zur Behandlung von Autismus und Asperger-Syndrom |
| US7344867B2 (en) | 2005-04-15 | 2008-03-18 | Eamonn Connolly | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| US9084434B2 (en) | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
| CN101668437A (zh) | 2007-03-13 | 2010-03-10 | N.V.努特里奇亚 | 使用含有非消化性糖的组合物改善能力的方法 |
| PT2438821T (pt) * | 2008-11-03 | 2020-04-22 | Nestle Sa | Composição nutricional compreendendo probióticos e melhorando os padrões de sono |
| US20110091431A1 (en) | 2009-10-09 | 2011-04-21 | Prothera, Inc. | Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
| CN103402376A (zh) | 2010-12-31 | 2013-11-20 | 雅培制药有限公司 | 促进有益细菌生长的中性人乳寡糖 |
| EP2609814A1 (en) * | 2011-12-30 | 2013-07-03 | Nestec S.A. | Lactobacillus reuteri DSM 17938 for the development of cognitive function |
| EP2609813A1 (en) * | 2011-12-30 | 2013-07-03 | Nestec S.A. | Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system |
| EP3212001A4 (en) | 2014-10-31 | 2018-04-25 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| HUE062788T2 (hu) * | 2016-04-15 | 2023-12-28 | Baylor College Medicine | Lactobacillus reuteri MM4-1A alkalmazása az autizmus spektrumzavar kezelésében vagy megelõzésében |
-
2017
- 2017-04-15 HU HUE17783343A patent/HUE062788T2/hu unknown
- 2017-04-15 FI FIEP17783343.1T patent/FI3442547T3/fi active
- 2017-04-15 LT LTEPPCT/US2017/027827T patent/LT3442547T/lt unknown
- 2017-04-15 RS RS20230719A patent/RS64503B1/sr unknown
- 2017-04-15 DK DK17783343.1T patent/DK3442547T3/da active
- 2017-04-15 US US16/093,593 patent/US11135252B2/en active Active
- 2017-04-15 WO PCT/US2017/027827 patent/WO2017181158A1/en active Application Filing
- 2017-04-15 SI SI201731398T patent/SI3442547T1/sl unknown
- 2017-04-15 EP EP23168971.2A patent/EP4238573A1/en active Pending
- 2017-04-15 ES ES17783343T patent/ES2954147T3/es active Active
- 2017-04-15 PL PL17783343.1T patent/PL3442547T3/pl unknown
- 2017-04-15 PT PT177833431T patent/PT3442547T/pt unknown
- 2017-04-15 EP EP17783343.1A patent/EP3442547B1/en active Active
- 2017-04-15 HR HRP20231030TT patent/HRP20231030T1/hr unknown
-
2021
- 2021-08-24 US US17/445,827 patent/US20210379123A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RS64503B1 (sr) | 2023-09-29 |
| ES2954147T3 (es) | 2023-11-20 |
| DK3442547T3 (da) | 2023-09-04 |
| SI3442547T1 (sl) | 2023-11-30 |
| WO2017181158A1 (en) | 2017-10-19 |
| HRP20231030T1 (hr) | 2023-12-22 |
| FI3442547T3 (fi) | 2023-09-05 |
| EP3442547A1 (en) | 2019-02-20 |
| EP3442547B1 (en) | 2023-06-07 |
| HUE062788T2 (hu) | 2023-12-28 |
| US11135252B2 (en) | 2021-10-05 |
| EP4238573A1 (en) | 2023-09-06 |
| US20210379123A1 (en) | 2021-12-09 |
| PL3442547T3 (pl) | 2023-10-23 |
| LT3442547T (lt) | 2023-09-25 |
| US20190070226A1 (en) | 2019-03-07 |
| EP3442547A4 (en) | 2019-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267082A (en) | Systems and methods for the treatment of neurological disorders | |
| IL279931A (en) | Gene therapies for lysosomal disorders | |
| HK1252741A1 (zh) | 用於治療神經疾病的組合物和方法 | |
| IL274407A (en) | Combined treatments | |
| IL279669A (en) | Gene therapies for lysosomal disorders | |
| IL278868A (en) | Gene therapies for lysosomal disorders | |
| EP3380000A4 (en) | METHOD AND DEVICE FOR SUPPLYING THE BRAIN WITH IRRITATION | |
| IL263680A (en) | Combination of treatments | |
| PT3442547T (pt) | Lactobacillus reuteri mm4-1a para utilização no tratamento ou prevenção de transtornos de espetro de autismo | |
| IL250994A0 (en) | Brain stimulation system and its uses | |
| IL274702A (en) | Compounds and Methods for Neurological Diseases | |
| PT3119911T (pt) | Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+ | |
| EP3092494A4 (en) | Biomarkers for dementia and dementia related neurological disorders | |
| IL267818A (en) | Methods for treating neurological disorders | |
| LT3183340T (lt) | Termolabilios egzonukleazės | |
| PL3432895T3 (pl) | Lizat osadu płytek krwi do stosowania w leczeniu zaburzeń neurologicznych | |
| SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
| GB201701404D0 (en) | Therapies for treating inflammatory disorders | |
| IL275613A (en) | Gene therapy for eosinophilic disorders | |
| ZA201700037B (en) | Compounds for the treatment of seizures and other central nervous system disorders and conditions | |
| ZA201807968B (en) | Binding of small particles | |
| GB201721043D0 (en) | Particles | |
| GB201717590D0 (en) | Particles | |
| GB201718386D0 (en) | The brain project | |
| GB201714565D0 (en) | Travel Pillow |